The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
The Fetal Basis of Amyloidogenesis: Exposure to Lead and Latent Overexpression of Amyloid Precursor Protein and β-Amyloid in the Aging Brain
Open accessAbstract
The fetal basis of adult disease (FeBAD) hypothesis states that many adult diseases have a fetal origin. According to FeBAD, injury or environmental influences occurring at critical periods of organ development could result in “programmatic” changes via alterations in gene expression or gene imprinting that may result in functional deficits that become apparent later in life. Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized by excessive deposits of aggregated β-amyloid (Aβ) peptides, which are snippets of the β-amyloid precursor protein (APP). The predominately sporadic nature of AD suggests that the environment must play a role in neurodegeneration. To examine latent responses to an environmental agent, we exposed rodents to lead and monitored the lifetime expression of the APP gene. We observed that APP mRNA expression was transiently induced in neonates, but exhibited a delayed overexpression 20 months after exposure to Pb had ceased. This upregulation in APP mRNA expression was commensurate with a rise in activity of the transcription factor Sp1, one of the regulators of the APP gene. Furthermore, the increase in APP gene expression in old age was accompanied by an elevation in APP and its amyloidogenic Aβ product. In contrast, APP expression, Sp1 activity, as well as APP and Aβ protein levels were unresponsive to Pb exposure during old age. These data suggested that environmental influences occurring during brain development predetermined the expression and regulation of APP later in life, potentially altering the course of amyloidogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
WEIGHT IN INFANCY AND DEATH FROM ISCHAEMIC HEART DISEASE
Barker, D. J. P., Osmond, C., Winter, P. D., Margetts, B., & Simmonds, S. J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90710-1 · Cited by 3,574
Casarett and Doull's Toxicology: The Basic Science of Poisons
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-448_2 · Cited by 3,302
Goyer, R. A., & Clarkson, T. W. (1991) · Cited by 1,200
The Long-Term Effects of Exposure to Low Doses of Lead in Childhood: An 11-Year Follow-up Report
Needleman, H. L., Schell, A., Bellinger, D., Leviton, A., & Allred, E. N. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001113220203 · Cited by 1,158
Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M. E., Romano, D. M., Hartshorn, M. A., Tanzi, R. E., & Bush, A. I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12817 · Cited by 1,009 · cited 1×
“Western blotting and quantitation procedures were performed as described previously (Atwood et al., 1998; Nunomura et al., 1999) with slight modifications.”
MethodFetal programming of coronary heart disease
BARKER, D. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(02)00689-6 · Cited by 678
Birthweight and adult health outcomes in a biethnic population in the USA
Valdez, R., Athens, M. A., Thompson, G. H., Bradshaw, B. S., & Stern, M. P. (1994) · Diabetologia · doi:10.1007/bf00403383 · Cited by 530
Exposure of the U.S. population to lead, 1991-1994.
Pirkle, J. L., Kaufmann, R. B., Brody, D. J., Hickman, T., Gunter, E. W., & Paschal, D. C. (1998) · Environmental Health Perspectives · doi:10.1289/ehp.98106745 · Cited by 397
The promoter of Alzheimer's disease amyloid A4 precursor gene.
Salbaum, J. M., Weidemann, A., Lemaire, H. G., Masters, C. L., & Beyreuther, K. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03136.x · Cited by 313
Transcriptional Regulation of BACE1, the β-Amyloid Precursor Protein β-Secretase, by Sp1
Christensen, M. A., Zhou, W., Qing, H., Lehman, A., Philipsen, S., & Song, W. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.865-874.2004 · Cited by 221
The Long-Term Effects of Exposure to Low Doses of Lead in Childhood
(1991) · New England Journal of Medicine · doi:10.1056/nejm199102073240612 · Cited by 216
Developmental Exposure to the Pesticides Paraquat and Maneb and the Parkinson’s Disease Phenotype
Thiruchelvam, M., Richfield, E. K., Goodman, B. M., Baggs, R. B., & Cory-Slechta, D. A. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00092-x · Cited by 214
Mechanisms of lead neurotoxicity, or looking beyond the lamppost
Silbergeld, E. K. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.13.1397842 · Cited by 186
Lahiri, D., Farlow, M., Sambamurti, K., Greig, N., Giacobini, E., & Schneider, L. (2003) · Current Drug Targets · doi:10.2174/1389450033346957 · Cited by 185
Self-citationMetabolic programming in animals
Ozanne, S. E. (2001) · British Medical Bulletin · doi:10.1093/bmb/60.1.143 · Cited by 179
Yarbrough, D. E., Barrett-Connor, E. L., Kritz‐Silverstein, D. C., & Wingard, D. L. (1998) · Diabetes Care · doi:10.2337/diacare.21.10.1652 · Cited by 140
Zawia, N. H., SHARAN, R., Brydie, M., Oyama, T., & Crumpton, T. L. (1998) · Developmental Brain Research · doi:10.1016/s0165-3806(98)00023-6 · Cited by 121
Self-citationMorishima-Kawashima, M., Oshima, N., Ogata, H., Yamaguchi, H., Yoshimura, M., Sugihara, S., & Ihara, Y. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64847-x · Cited by 119 · cited 1×
“The assay conditions were followed according to the method described by Morishima-Kawashima et al. (2000), with slight modifications as suggested by the manufacturers.”
MethodNeuronal RNA Oxidation in Alzheimer's Disease and Down's Syndrome
Nunomura, A., Perry, G. L., Hirai, K., Aliev, G., Takeda, A., Chiba, S., & Smith, M. A. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07855.x · Cited by 112
Basha, R. M., Wei, W., Brydie, M., Razmiafshari, M., & Zawia, N. H. (2003) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(02)00137-5 · Cited by 102
Self-citationLahiri, D. K., & Robakis, N. K. R. K. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90009-m · Cited by 94
Self-citationPollwein, P., Masters, C. L., & Beyreuther, K. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.1.63 · Cited by 91
Characterization of the 5′-end region and the first two exons of the β-protein precursor gene
Fauci, G. L., Lahiri, D. K., Salton, S. R., & Robakis, N. K. R. K. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92437-6 · Cited by 67
Self-citationGe, Y., Maloney, B., Sambamurti, K., & Lahiri, D. K. (2004) · The FASEB Journal · doi:10.1096/fj.03-1379fje · Cited by 61
Self-citationDelayed neurotoxicity in monkeys exposed developmentally to methylmercury.
Dc, R. (1989) · PubMed · Cited by 48
Efficacy of Succimer Chelation for Reducing Brain Pb Levels in a Rodent Model
Smith, D. R., Bayer, L. E., & Strupp, B. J. (1998) · Environmental Research · doi:10.1006/enrs.1998.3854 · Cited by 47
Nishimura, I., Uetsuki, T., Kuwako, K.-I., Hara, T., Kawakami, T., Aimoto, S., & Yoshikawa, K. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400931 · Cited by 46
Neurotoxic effects of neonatal triethyltin (TET) exposure are exacerbated with aging
Barone, S., Stanton, M. E., & Mundy, W. R. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00089-w · Cited by 43
Smith, C. J., Wion, D., & Brachet, P. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90095-f · Cited by 39
Enhancer function and novel DNA binding protein activity in the near upstream βAPP gene promoter
Querfurth, H. W., Jiang, J. C., Xia, W., & Selkoe, D. J. (1999) · Gene · doi:10.1016/s0378-1119(99)00091-8 · Cited by 36
Transcriptional involvement in neurotoxicity
Zawia, N. H. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00161-3 · Cited by 28
Self-citationReeves, R., Thiruchelvam, M. J., Richfield, E. K., & Cory‐Slechta, D. A. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.08.003 · Cited by 24
Basha, R. M., Wei, W., Reddy, G. R., & Zawia, N. (2004) · Informa Healthcare eBooks · doi:10.1201/9780203503317.ch3 · Cited by 2
Self-citation
Cited by
Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 3,850
Chin-Chan, M., Navarro-Yepes, J., & Quintanilla-Vega, B. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00124 · Cited by 707
Histone acetylation: molecular mnemonics on the chromatin
Gräff, J., & Tsai, L.-H. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3427 · Cited by 680
Karri, V., Schuhmacher, M., & Kumar, V. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.09.016 · Cited by 514
Wu, J., Basha, M. R., Brock, B., Cox, D. P., Cardozo-Pelaez, F., McPherson, C. A., Harry, J., Rice, D. C., Maloney, B., Chen, D., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4405-07.2008 · Cited by 470
Self-citation
Metadata
- Authors
- Basha, M. R., Wei, W., Bakheet, S. A., Benitez, N., Siddiqi, H. K., Ge, Y.-W., Lahiri, D. K., & Zawia, N. H.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2005-01-26
- Volume
- 25
- Issue
- 4
- Pages
- 823-829
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2129489564
- Cited by
- 349
- References
- 35
- FWCI
- 8.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.